Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

VaccImm: simulating peptide vaccination in cancer therapy.

von Eichborn J, Woelke AL, Castiglione F, Preissner R.

BMC Bioinformatics. 2013 Apr 15;14:127. doi: 10.1186/1471-2105-14-127.

PMID:
23586423
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Development of immune-specific interaction potentials and their application in the multi-agent-system VaccImm.

Woelke AL, von Eichborn J, Murgueitio MS, Worth CL, Castiglione F, Preissner R.

PLoS One. 2011;6(8):e23257. doi: 10.1371/journal.pone.0023257. Epub 2011 Aug 17.

PMID:
21858048
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Multipeptide vaccination in cancer patients.

Pilla L, Rivoltini L, Patuzzo R, Marrari A, Valdagni R, Parmiani G.

Expert Opin Biol Ther. 2009 Aug;9(8):1043-55. doi: 10.1517/14712590903085109. Review.

PMID:
19591629
[PubMed - indexed for MEDLINE]
4.

OptiTope--a web server for the selection of an optimal set of peptides for epitope-based vaccines.

Toussaint NC, Kohlbacher O.

Nucleic Acids Res. 2009 Jul;37(Web Server issue):W617-22. doi: 10.1093/nar/gkp293. Epub 2009 May 6.

PMID:
19420066
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

Parmiani G, Castelli C, Dalerba P, Mortarini R, Rivoltini L, Marincola FM, Anichini A.

J Natl Cancer Inst. 2002 Jun 5;94(11):805-18. Review.

PMID:
12048268
[PubMed - indexed for MEDLINE]
Free Article
6.

Antitumor vaccination using peptide based vaccines.

Eisenbach L, Bar-Haim E, El-Shami K.

Immunol Lett. 2000 Sep 15;74(1):27-34. Review.

PMID:
10996624
[PubMed - indexed for MEDLINE]
7.

WT1 peptide vaccine as a paradigm for "cancer antigen-derived peptide"-based immunotherapy for malignancies: successful induction of anti-cancer effect by vaccination with a single kind of WT1 peptide.

Oka Y, Tsuboi A, Fujiki F, Li Z, Nakajima H, Hosen N, Shirakata T, Nishida S, Oji Y, Kawase I, Sugiyama H.

Anticancer Agents Med Chem. 2009 Sep;9(7):787-97. Epub 2009 Sep 1. Review.

PMID:
19538172
[PubMed - indexed for MEDLINE]
8.

Rational Peptide-based vaccine design for cancer immunotherapeutic applications.

Lazoura E, Apostolopoulos V.

Curr Med Chem. 2005;12(6):629-39. Review.

PMID:
15790302
[PubMed - indexed for MEDLINE]
9.

Peptide-based anticancer vaccines: recent advances and future perspectives.

Mocellin S, Pilati P, Nitti D.

Curr Med Chem. 2009;16(36):4779-96. Review.

PMID:
19929787
[PubMed - indexed for MEDLINE]
10.

Specific immunotherapy of cancer in elderly patients.

Matzku S, Zöller M.

Drugs Aging. 2001;18(9):639-64. Review.

PMID:
11599633
[PubMed - indexed for MEDLINE]
11.

T-cell epitope analogues from carcinoembryonic antigen for vaccination against cancer: WO2009002418.

Hallermalm K.

Expert Opin Ther Pat. 2009 Nov;19(11):1635-7. doi: 10.1517/13543770903099659.

PMID:
19566377
[PubMed - indexed for MEDLINE]
12.

Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting.

Slingluff CL Jr, Petroni GR, Chianese-Bullock KA, Smolkin ME, Hibbitts S, Murphy C, Johansen N, Grosh WW, Yamshchikov GV, Neese PY, Patterson JW, Fink R, Rehm PK.

Clin Cancer Res. 2007 Nov 1;13(21):6386-95.

PMID:
17975151
[PubMed - indexed for MEDLINE]
Free Article
13.

Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay.

Pass HA, Schwarz SL, Wunderlich JR, Rosenberg SA.

Cancer J Sci Am. 1998 Sep-Oct;4(5):316-23.

PMID:
9815296
[PubMed - indexed for MEDLINE]
14.

Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapies.

Chianese-Bullock KA, Lewis ST, Sherman NE, Shannon JD, Slingluff CL Jr.

Vaccine. 2009 Mar 10;27(11):1764-70. doi: 10.1016/j.vaccine.2009.01.018. Epub 2009 Feb 8.

PMID:
19185050
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Peptide vaccine.

Izumoto S.

Adv Exp Med Biol. 2012;746:166-77. doi: 10.1007/978-1-4614-3146-6_13. Review.

PMID:
22639167
[PubMed - indexed for MEDLINE]
16.

Development of anti-PAX3 immune responses; a target for cancer immunotherapy.

Himoudi N, Nabarro S, Yan M, Gilmour K, Thrasher AJ, Anderson J.

Cancer Immunol Immunother. 2007 Sep;56(9):1381-95. Epub 2007 Feb 23.

PMID:
17318653
[PubMed - indexed for MEDLINE]
17.

The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?

Slingluff CL Jr.

Cancer J. 2011 Sep-Oct;17(5):343-50. doi: 10.1097/PPO.0b013e318233e5b2. Review.

PMID:
21952285
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting.

Dutoit V, Taub RN, Papadopoulos KP, Talbot S, Keohan ML, Brehm M, Gnjatic S, Harris PE, Bisikirska B, Guillaume P, Cerottini JC, Hesdorffer CS, Old LJ, Valmori D.

J Clin Invest. 2002 Dec;110(12):1813-22.

PMID:
12488431
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Dendritic cell gene therapy.

Onaitis M, Kalady MF, Pruitt S, Tyler DS.

Surg Oncol Clin N Am. 2002 Jul;11(3):645-60. Review.

PMID:
12487060
[PubMed - indexed for MEDLINE]
20.

Cancer treatment: the combination of vaccination with other therapies.

Andersen MH, Sørensen RB, Schrama D, Svane IM, Becker JC, Thor Straten P.

Cancer Immunol Immunother. 2008 Nov;57(11):1735-43. doi: 10.1007/s00262-008-0480-y. Epub 2008 Feb 20. Review.

PMID:
18286284
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk